This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Raxone
  • /
  • Study to Assess Efficacy,Safety and Tolerability o...
Clinical trial

Study to Assess Efficacy,Safety and Tolerability of Idebenone in the Treatment of Leber's Hereditary Optic Neuropathy (RHODOS)

Read time: 1 mins
Last updated:1st Nov 2007

This study is meant to assess the effectiveness of idebenone on visual function measures in patients with Leber's Hereditary Optic Neuropathy over a 6 months period.

Study Type: Interventional
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Patients With Leber's Hereditary Optic Neuropathy
Enrollment: 85
Study Start Date: November 2007
Study Completion Date: February 2010
Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)

- Experimental:
- Placebo Comparator: 2

Related journals:
A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy.

Effects of idebenone on color vision in patients with leber hereditary optic neuropathy.

Category Value
Study start date 2007-11-01

View full details